Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Zeocin® Chimeric single-chain variable fragment-human immunoglobulin G crystallizable... 2023 Explor Target Antitumor Ther. Laopajon W. et al. DOI: 10.37349/etat.2023.00188
2'3'-cGAMP cGAS-STING signalling regulates microglial chemotaxis in genome instability. 2023 Nucleic Acids Res. Talbot E.J. et al. DOI: 10.1093/nar/gkad1184
Plasmocin® - Mycoplasma Elimination Reagent 2-Deoxy-glucose ameliorates the peritoneal mesothelial and endothelial barrie... 2024 BBRC Pitaraki E. et al. DOI: 10.1016/j.bbrc.2023.149376
IAP inhibitor - BV6 Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies... 2023 Inflamm Bowel Dis. Tao S. et al. DOI: 10.1093/ibd/izad291
Pan-Caspase inhibitor - Z-VAD-FMK Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies... 2023 Inflamm Bowel Dis. Tao S. et al. DOI: 10.1093/ibd/izad291
Zeocin® Efficient selection of knocked-in pluripotent stem cells using a dual cassett... 2023 Cell Rep Methods Nakade K. et al. DOI: 10.1016/j.crmeth.2023.100662
LPS-EB (LPS from E. coli O111:B4) Extracellular vesicles and co-isolated endogenous retroviruses from murine ca... 2023 EMBO J. Cocozza F. et al. DOI: 10.15252/embj.2023113590
ODN 1585 - TLR9 ligand Tumor nano-lysate activates dendritic cells to evoke a preventative immune re... 2024 J Immunol Methods Dombroski J.A. et al. DOI: 10.1016/j.jim.2023.113601
ODN 1585 VacciGrade™ Tumor nano-lysate activates dendritic cells to evoke a preventative immune re... 2024 J Immunol Methods Dombroski J.A. et al. DOI: 10.1016/j.jim.2023.113601
G418 (Geneticin) CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by act... 2024 Life Sci. Liu Y.N. et al. DOI: 10.1016/j.lfs.2023.122345
Puromycin CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by act... 2024 Life Sci. Liu Y.N. et al. DOI: 10.1016/j.lfs.2023.122345
QUANTI-Blue™ ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... 2023 PNAS Snelling T. et al. DOI: 10.1073/pnas.2313148120
HEK-Blue™ Null1-v Cells ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... 2023 PNAS Snelling T. et al. DOI: 10.1073/pnas.2313148120
KO ALPK1 & KO TIFA cells ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... 2023 PNAS Snelling T. et al. DOI: 10.1073/pnas.2313148120
LumiKine™ Xpress mIFN-β 2.0 Glabridin improves autoimmune disease in Trex1-deficient mice by reducing typ... 2023 Mol Med. Wen J. et al. DOI: 10.1186/s10020-023-00754-y
Zeocin® Protocol for producing an adeno-associated virus vector by controlling capsid... 2023 STAR Protoc. Ohba K & Mizukami H. DOI: 10.1016/j.xpro.2023.102542
Blasticidin Protocol for producing an adeno-associated virus vector by controlling capsid... 2023 STAR Protoc. Ohba K & Mizukami H. DOI: 10.1016/j.xpro.2023.102542
R848 (Resiquimod) Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tum... 2023 J Immunother Cancer Toffoli E.C. et al. DOI: 10.1136/jitc-2023-007554
LTA-SA Mesenchymal stromal cells suppress microglial activation and tumor necrosis f... 2023 Cytotherapy Xu L. et al. DOI: 10.1016/j.jcyt.2023.11.006
TLR4-based adjuvant - MPLA-SM VacciGrade™ Leptospira Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity aga... 2023 Vaccines (Basel) Varma V.P. et al. DOI: 10.3390/vaccines11121824

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty